Differences in the osteoarthritic synovial fluid composition and rheology between patients with or without flare-up: A pilot study

Clinical and Experimental Rheumatology

Volumn 30, Issue 5, 2012, Pages 729-734

  Conrozier, T ^a   Mathieu, P ^a   Vignon, E ^a   Piperno, M ^a   Rinaudo, M ^b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b CENTRE DE RECHERCHES SUR LES MACROMOLÉCULES VÉGÉTALES CERMAV CNRS   (France)

Author keywords

Flare; Hyaluronic acid; Knee osteoarthritis; Proteins; Rheology; Synovial fluid

Indexed keywords

HYALURONIC ACID;

ADULT; AGED; ARTHROCENTESIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INFLAMMATION; JOINT EFFUSION; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; PRIORITY JOURNAL; SYNOVIAL FLUID; VISCOSITY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHROMATOGRAPHY, GEL; DISEASE PROGRESSION; FEMALE; HUMANS; HYALURONIC ACID; KNEE JOINT; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OSTEOARTHRITIS, KNEE; PARACENTESIS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROTEINS; RHEOLOGY; SYNOVIAL FLUID; VISCOSITY;

EID: 84870260384     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. AMERICAN COLLEGE OF RHEUMATOLOGY SUBCOMMITTEE ON OSTEOARTHRITIS GUIDELINES: Recommendations for the medical management of osteoarthritis of the hip and the knee. 2000 update. Arthritis Rheum 2000;43:1905-15.
2. ZHANG W, DOHERTY M, PEAT G et al.: EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis 2010;69:483-9.
3. ZHANG W, NUKI G, MOSKOWITZ RW et al.: OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99.
4. MARTY M, HILLIQUIN P, ROZENBERG S et al.: Validation of the KOFUS (Knee Osteoarthritis Flare-Ups Score). Joint Bone Spine 2009;76:268-72.
5. D'AGOSTINO MA, CONAGHAN P, LE BARS M et al.: EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritis. Ann Rheum Dis 2005;64:1703-9.
6. IAGNOCCO A, MEENAGH G, RIENTE L et al.: Ultrasound imaging for the Traumatologist XXIX. Sonographic assessment of the knee in patients with osteoarthritis. Clin Exp Rheumatol 2010;28:643-46.
7. FAM H, BRYANT JT, KONTOPOULO M: Rheological properties of synovial fluids. Biorheology 2007;44:59-74.
8. BALAZS EA, WATSON D, DUFF IF, ROSEMAN S: Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967;10:357-76.
9. WADDELL DD, MARINO AA: Chronic knee effusions in patients with advanced osteoarthritis: implications for functional outcome of viscosupplementation. J Knee Surg 2007;20:181-4.
10. GOMEZ JE, THURSTON GB: Comparisons of the oscillatory shear viscoelasticity and composition of pathological synovial fluid. Biorheology 1993;30:409-27.
11. RINAUDO M: Advances in characterisation of polysaccharides in aqueous solution and gel state. In: DIMITRIU S, ed. Polysaccharides: Structural Diversity and Functional Versatility. Ed 2. New York, NY: Marcel Dekker; 2004:237-52.
12. RINAUDO M, ROURE I, MILAS M: Use of steric exclusion chromatography to characterize hyaluronan, a semi-rigid polysaccharide. Int J Polym Anal Charact 1999;5:277-87.
13. MILAS M, RINAUDO M, ROURE I, AL-ASSAF S, PHILLIPS GO, WILLIAMS PA: Rheological behaviour of hyaluronan, healon and hylan in aqueous solution. In: KENNEDY JF, PHILLIPS GO, WILLIAMS PA, HASCALL VC, eds. Hyaluronan, Volume 1: Chemical, Biochemical and Biological Aspects. Cambridge, UK: Woodhead Publishing; 2002:181-93.
14. VENDRELY C, VALADIE H, BEDNAROVA L et al.: Assembly of the full-length recombinant mouse prion protein I: formation of soluble oligomers. Biochim Biophys Acta 2005;1724:355-66.
15. BALAZS EA: Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain. Cells Tissues Organs 2003;174:49-62
16. BALAZS EA: Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg Technol Inter 2004;12:278-89.
17. BALAZS EA, DENLINGER JL: Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993;39:3-9.
18. DAHL LB, DAHL IM, ENGSTRÖM-LAURENT A, GRANATH K: Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817-22.
19. KRAUS VB, STABLER TV, KONG SY, VARJU G, MCDANIEL G: Measurement of synovial fluid volume using urea. Osteoarthritis Cartilage 2007;15:1217-20.
20. BERRIAUD N, MILAS M, RINAUDO M: Rheological study on mixtures of different molecular weight hyaluronates. Int J Biol Macromol 1994;16:137-42.
21. CAMENISH TD, MCDONALD JA: Hyaluronan: is bigger better? Am J Resp Cell Mol Biol 2000;23:431-3.
22. FERGUSSON J, BOYLE JA, McSWEEN NM, JASANI MK: Observations on the flow properties of the synovial fluid from patients with rheumatoid arthritis. Biorheology 1968;5:119-31.
23. MATHIEU P, CONROZIER T, VIGNON E, ROZAND Y, RINAUDO M: Rheologic behavior of osteoarthritic synovial fluid after addition of hyaluronic acid: a pilot study. Clin Orthop Relat Res 2009;467:3002-9.
24. MAGNANI A, PATTACINI L, BOIARDI L, CASALI B, SALVARANI C: Reelin levels are increased in synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2010;28:546-8.